(Q50917481)

25 March 2018

title

Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy. (English)

1 reference

25 March 2018

Adaptive radiation therapy

main subject

0 references

1 reference

John W Robinson

1

1 reference

25 March 2018

Bryan J Donnelly

2

1 reference

25 March 2018

Kerry Coupland

3

1 reference

25 March 2018

Jodi E Siever

4

1 reference

25 March 2018

John C Saliken

5

1 reference

25 March 2018

Cheryl Scott

6

1 reference

25 March 2018

P M A Brasher

7

1 reference

25 March 2018

D Scott Ernst

8

1 reference

25 March 2018

publication date

1 November 2006

1 reference

25 March 2018

published in

Urologic Oncology

1 reference

25 March 2018

volume

24

1 reference

25 March 2018

issue

6

1 reference

25 March 2018

page(s)

472-486

1 reference

25 March 2018

Current status of local salvage therapies following radiation failure for prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Salvage prostatectomy in patients who have failed radiation therapy or cryotherapy as primary treatment for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Quality of life in patients undergoing salvage procedures for locally recurrent prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Salvage radical prostatectomy: Refinement of an effective procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Third-generation cryosurgery for primary and recurrent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Prostate cancer: cryotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

The evolution and state of modern technology for prostate cryosurgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

Endocrine treatment of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.03.007

10.1016/J.UROLONC.2006.03.007

7 January 2021

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

17138127

1 reference

25 March 2018